169 related articles for article (PubMed ID: 28736065)
1. Common variable immunodeficiency-associated granulomatous and lymphocytic interstitial lung disease successfully treated with a combination regimen of rituximab and azathioprine.
Moctezuma SI; Panizo CM; Landecho MF
Med Clin (Barc); 2017 Oct; 149(7):312-313. PubMed ID: 28736065
[No Abstract] [Full Text] [Related]
2. Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency.
Pathria M; Urbine D; Zumberg MS; Guarderas J
BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27335365
[TBL] [Abstract][Full Text] [Related]
3. Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
Verbsky JW; Hintermeyer MK; Simpson PM; Feng M; Barbeau J; Rao N; Cool CD; Sosa-Lozano LA; Baruah D; Hammelev E; Busalacchi A; Rymaszewski A; Woodliff J; Chen S; Bausch-Jurken M; Routes JM
J Allergy Clin Immunol; 2021 Feb; 147(2):704-712.e17. PubMed ID: 32745555
[TBL] [Abstract][Full Text] [Related]
4. Rituximab as a Single Agent for Granulomatous Lymphocytic Interstitial Lung Disease in Common Variable Immune Deficiency.
Tessarin G; Bondioni MP; Rossi S; Palumbo L; Soresina A; Badolato R; Plebani A; Lougaris V
J Investig Allergol Clin Immunol; 2019 Dec; 29(6):470-471. PubMed ID: 31825316
[No Abstract] [Full Text] [Related]
5. Serum IL-12 and soluble IL-2 receptor levels as possible biomarkers of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency: a case report.
Vitale J; Convers KD; Goretzke S; Guzman M; Noyes B; Parkar N; Knutsen AP
J Allergy Clin Immunol Pract; 2015; 3(2):273-6. PubMed ID: 25609323
[No Abstract] [Full Text] [Related]
6. Successful rituximab treatment of granulomatous/lymphocytic interstitial lung disease in common variable immunodeficiency.
Králíčková P; Kubcová Š; Kočová E; Bartoš V; Souček O; Rozsíval P; Vaníček H; Krčmová I; Ravčuková B; Grombiříková H; Freiberger T
Epidemiol Mikrobiol Imunol; 2018; 67(3):142-148. PubMed ID: 30602282
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency.
Cereser L; De Carli R; Girometti R; De Pellegrin A; Reccardini F; Frossi B; De Carli M
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1055-1057.e2. PubMed ID: 30408616
[No Abstract] [Full Text] [Related]
8. Rituximab as a single agent for successful treatment of granulomatous and lymphocytic interstitial lung disease in a pediatric patient with common variable immunodeficiency.
Kosinski SM; Nachajon RV; Milman E
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):876-878.e1. PubMed ID: 34718215
[No Abstract] [Full Text] [Related]
9. Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease.
Ng J; Wright K; Alvarez M; Hunninghake GM; Wesemann DR
Chest; 2019 May; 155(5):e117-e121. PubMed ID: 31060706
[TBL] [Abstract][Full Text] [Related]
10. Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients.
Tessarin G; Baronio M; Gazzurelli L; Rossi S; Chiarini M; Moratto D; Giliani SC; Bondioni MP; Badolato R; Lougaris V
J Clin Immunol; 2023 Nov; 43(8):2091-2103. PubMed ID: 37755605
[TBL] [Abstract][Full Text] [Related]
11. Granulomatous-Lymphocytic Interstitial Lung Disease in a Patient With Common Variable Immunodeficiency.
Shah JL; Amin SB; Verma N; Mohammed TL
Curr Probl Diagn Radiol; 2018; 47(4):282-284. PubMed ID: 28583689
[TBL] [Abstract][Full Text] [Related]
12. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).
Chase NM; Verbsky JW; Hintermeyer MK; Waukau JK; Tomita-Mitchell A; Casper JT; Singh S; Shahir KS; Tisol WB; Nugent ML; Rao RN; Mackinnon AC; Goodman LR; Simpson PM; Routes JM
J Clin Immunol; 2013 Jan; 33(1):30-9. PubMed ID: 22930256
[TBL] [Abstract][Full Text] [Related]
13. FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID).
Jolles S; Carne E; Brouns M; El-Shanawany T; Williams P; Marshall C; Fielding P
Clin Exp Immunol; 2017 Jan; 187(1):138-145. PubMed ID: 27896807
[TBL] [Abstract][Full Text] [Related]
14. Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey.
van de Ven AAJM; Alfaro TM; Robinson A; Baumann U; Bergeron A; Burns SO; Condliffe AM; Fevang B; Gennery AR; Haerynck F; Jacob J; Jolles S; Malphettes M; Meignin V; Milota T; van Montfrans J; Prasse A; Quinti I; Renzoni E; Stolz D; Warnatz K; Hurst JR
Front Immunol; 2020; 11():606333. PubMed ID: 33324422
[TBL] [Abstract][Full Text] [Related]
15. [Granulomatous lymphocytic interstitial lung disease (GLILD) as a manifestation of pulmonary changes in common variable immunodeficiency (CVID) – case report].
Marciszewska E; Szaflarska A; Pituch-Noworolska A
Przegl Lek; 2016; 73(7):530-3. PubMed ID: 29677427
[TBL] [Abstract][Full Text] [Related]
16. Crohn's-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab.
Vázquez-Morón JM; Pallarés-Manrique H; Martín-Suárez IJ; Benítez-Rodríguez B; Ramos-Lora M
Rev Esp Enferm Dig; 2013; 105(5):299-302. PubMed ID: 23971663
[TBL] [Abstract][Full Text] [Related]
17. Successful Treatment of ANCA-Associated Vasculitis in the Setting of Common Variable Immunodeficiency Using Rituximab.
Hill F; Yonkof J; Chaitanya Arudra SK; Thomas J; Altorok N
Am J Ther; 2016; 23(5):e1239-45. PubMed ID: 26291596
[TBL] [Abstract][Full Text] [Related]
18. Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis.
Watanabe R; Ishii T; Araki K; Ishizuka M; Kamogawa Y; Fujita Y; Shirota Y; Fujii H; Harigae H
Mod Rheumatol; 2016; 26(3):465-6. PubMed ID: 25698368
[No Abstract] [Full Text] [Related]
19. Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency.
Tashtoush B; Memarpour R; Ramirez J; Bejarano P; Mehta J
Clin Respir J; 2018 Jan; 12(1):337-343. PubMed ID: 27243233
[TBL] [Abstract][Full Text] [Related]
20. Common variable immunodeficiency-associated granulomatous and interstitial lung disease.
Prasse A; Kayser G; Warnatz K
Curr Opin Pulm Med; 2013 Sep; 19(5):503-9. PubMed ID: 23880700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
